NAD+ is a naturally occurring cellular coenzyme studied in metabolism, redox biology and enzyme-signaling research. Ryse NAD+ products are offered solely as laboratory-research materials and are not intended for human or veterinary use. FDA has specifically cautioned compounders that food-grade NAD+ ingredients are not suitable for sterile drug compounding without appropriate controls because of contamination and endotoxin risks.
What Researchers Study NAD+ For
Published laboratory, animal and human research has examined NAD+ biology in the following areas:
Evidence represented: Laboratory • Animal • Human biomarker research
- Electron transfer during cellular metabolismLaboratory
- Mitochondrial metabolismLaboratory and animal
- NAD+ and NADH redox balanceLaboratory
- DNA-damage response pathwaysLaboratory and animal
- Sirtuin-related enzyme signalingLaboratory and animal
- PARP and CD38-related NAD+ consumptionLaboratory and animal
- Age-associated metabolic changesAnimal and human biomarker
These topics describe areas of scientific investigation. Evidence involving NAD+ precursors, biomarkers, experimental models or clinical formulations should not be interpreted as established outcomes for a commercial NAD+ product.
What should you know first?
NAD+ has a well-established role in cellular redox chemistry and metabolism, while research on commercial formats, clinical outcomes and generalized wellness claims remains much less certain.
- NAD+ accepts electrons and becomes NADH during many metabolic reactions.
- Sirtuins, PARPs and CD38 use or consume NAD+ in signaling pathways.
- Much human evidence concerns NMN, NR or other precursors—not NAD+ itself.
- A product label or purity percentage cannot establish pharmaceutical equivalence, sterility or an outcome.
What Is NAD+?
NAD+ is a cellular coenzyme rather than a peptide. It participates in electron-transfer reactions involved in cellular metabolism and also serves as a substrate for several enzyme families involved in cellular signaling.
A useful simplified analogy is a cellular shuttle: oxidized NAD+ can accept electrons during one reaction and become NADH; NADH can later donate reducing equivalents in another reaction. The chemistry is more complex than the analogy, but it helps explain why the pair continually cycles between forms.
NAD+ participates in glycolysis, the citric-acid cycle, mitochondrial energy metabolism, oxidation-reduction reactions and enzyme-dependent consumption pathways. Its presence in a peptide-oriented catalog does not make it a peptide.
Why NAD+ Is Not a Peptide
Peptides are chains of amino acids. NAD+ is assembled from nucleotide-related components and has a different structure and biological classification.
NAD+ contains nicotinamide and adenine nucleotide portions. It is a dinucleotide coenzyme, not a peptide, protein, peptide hormone or vitamin.
Cells can make it using vitamin B3-related precursors, but the completed coenzyme is not itself vitamin B3.
NAD+ Versus NADH
NAD+ is the oxidized electron-accepting form; NADH is the reduced electron-carrying form. Neither is simply a “better” or “more energetic” version of the other.
NAD+
- Oxidized form
- Can accept electrons
- Participates in metabolism and enzyme signaling
- The plus sign reflects chemical charge
NADH
- Reduced form
- Carries electrons and hydrogen equivalents
- Can donate electrons in later reactions
- Participates in cellular energy pathways
Researchers often study the NAD+/NADH ratio because cycling between these forms reflects aspects of cellular redox balance.
How NAD+ Participates in Cellular Metabolism
NAD+ is required for many enzyme-driven reactions that convert nutrients into forms of cellular energy.
When NAD+ accepts reducing equivalents, NADH forms. NADH can transfer those equivalents into later reactions, including mitochondrial electron transport associated with ATP production.
This chemistry connects glycolysis, the citric-acid cycle and mitochondrial metabolism.
That core biochemical role does not establish that a Ryse NAD+ product increases a person’s perceived energy or produces a clinical outcome.
NAD-Dependent Enzyme Signaling
NAD+ is not only a redox coenzyme; several signaling-enzyme families consume it as a substrate.
Sirtuins
- NAD-dependent enzymes
- Studied in metabolic regulation
- Gene-expression and cellular-stress research
- Mitochondrial and age-associated biology
PARPs
- Poly-ADP-ribose polymerases
- Use NAD+ in DNA-damage response signaling
- A pathway measurement does not mean a catalog product repairs DNA
CD38
- Enzyme that consumes NAD+
- Also involved in calcium-related signaling
- Studied in inflammatory and aging models
NAD+ Versus Its Precursors
A precursor is a substance cells may use to make another molecule. NMN, NR, nicotinamide and niacin can contribute to NAD+ biosynthesis, but they are not interchangeable with NAD+.
NAD+
- Complete oxidized coenzyme
- Direct participant in redox reactions
- Has its own stability and uptake questions
NMN and NR
- Nucleotide-related precursors
- Studied as inputs to NAD+ biosynthesis
- Human evidence must be labeled as precursor evidence
Nicotinamide and niacin
- Vitamin B3-related compounds
- Enter NAD+ biosynthesis through different pathways
- May also have compound-specific biology
Oral precursor studies should not be presented as direct studies of an NAD+ vial or strip. Compound structure, formulation, uptake, metabolism and pharmacokinetics differ.
What questions are researchers studying?
Researchers examine NAD+ biology across metabolism, mitochondrial function, redox balance, nutrient sensing and enzyme-signaling systems.
These are scientific questions, not proof that a commercial NAD+ product improves energy, reverses aging or treats a condition.
- Cellular energy metabolism and mitochondrial function
- NAD+/NADH redox balance and nutrient sensing
- Sirtuin, PARP and CD38 activity
- DNA-damage response and calcium-signaling pathways
- Metabolic stress, exercise and skeletal-muscle models
- Inflammation-related, neurological and cardiovascular models
- Cellular senescence and age-associated metabolic change
- NAD+ precursor studies and human NAD-related biomarkers
What should you know first?
Evidence status: strong biological foundation, but product-specific human outcomes remain uncertain.
- NAD+ has a well-established biochemical role supported by extensive laboratory research.
- Animal studies examine NAD+ metabolism across tissues and experimental models.
- Human research frequently evaluates precursors and NAD-related biomarkers rather than NAD+ itself.
- Biomarker changes do not automatically establish meaningful functional outcomes.
- Evidence involving a precursor or clinical formulation does not establish results for a Ryse product.
What have laboratory and animal studies examined?
Laboratory and animal models help researchers identify mechanisms and test hypotheses; they cannot establish an outcome in people.
Experimental work has examined cellular NAD+ depletion, mitochondrial metabolism, oxidative-stress measurements, sirtuin signaling, PARP activation, CD38 activity, DNA-damage response pathways and metabolic stress.
Models involving exercise, aging, neurological systems, cardiovascular systems and skeletal muscle provide mechanistic context. Findings remain tied to the material, model, conditions and endpoints actually studied.
What do human studies tell us?
Human research often focuses on nicotinamide riboside, nicotinamide mononucleotide, niacin-related compounds or biomarkers—not a commercial NAD+ product.
Common measurements include blood or cellular NAD-related metabolites, glucose and lipid markers, vascular measurements, exercise-related measurements and selected functional outcomes. Trials may show biochemical changes while broader findings remain variable, limited or endpoint-specific.
Human research involving an NAD+ precursor should not be described as direct evidence for NAD+ itself or for a Ryse NAD+ product.
Direct NAD+ Research Versus Precursor Evidence
The two evidence categories should not be merged because intact NAD+ and its precursors have different stability, uptake, metabolism and pharmacokinetic questions.
Direct NAD+ research
- Cellular or biochemical experiments
- Pharmacokinetic research
- Clinical or compounded preparations
- Limited pilot research
- Direct pathway measurements
NAD+ precursor research
- NMN, NR, nicotinamide or niacin
- Oral precursor studies
- Human biomarker trials
- Requires conversion within biosynthetic pathways
What are the limits of the current evidence?
NAD+ biology is foundational, but that foundation does not establish a commercial-product benefit or broad clinical outcome.
Compounded drugs are not FDA-approved products. FDA’s warning is not an approval of NAD+ therapy, does not convert Ryse material into a compounded drug and does not establish that a food-grade ingredient is suitable for sterile use.
- Much human research evaluates precursors rather than NAD+ itself.
- Biomarker changes do not automatically produce functional or clinical improvements.
- Human studies are often small, short or limited to selected populations.
- Results vary by compound, formulation, route, tissue and measured outcome.
- Evidence for generalized anti-aging, energy or wellness outcomes remains inconclusive.
- Study findings do not verify the identity, quality or performance of a Ryse product.
- FDA cautions that food-grade NAD+ is not suitable for sterile drug compounding without appropriate controls because microbial and endotoxin contamination are separate risks.
Product Identity and Format Differences
The repository verifies three separate Ryse records: 500 mg vial, 1000 mg vial, and 100 mg / 30-count strips. Their labels do not establish analytical equivalence.
The vial labels identify NAD+, total vial mass, a 3 mL vial and research-use language. The strip label identifies “oral dissolving peptide strips,” NAD+ and 100 mg / 30 count.
That package phrase is reported for identification only; NAD+ remains a non-peptide coenzyme.
The reviewed catalog records and labels do not specify a salt, hydrate or molecular formula, so no exact chemical form is assigned here. A vial’s appearance does not establish an approved or intended administration route.
- A label alone does not establish oxidized versus reduced form, salt or hydrate, molecular mass, purity or concentration.
- Purity, water content, degradation, microbial quality, endotoxin and sterility are distinct questions.
- Each format must be matched to its own product record, batch and documentation.
- Only a bundled COA titled NAD+ 500 mg was located; it is not assigned to the other formats.
Understanding an NAD+ COA
A useful Certificate of Analysis connects the exact product, format and batch to named methods, results, dates and limitations.
HPLC may describe chromatographic composition under stated conditions; mass spectrometry may support molecular identity. Neither method alone establishes every quality attribute.
A high purity percentage does not establish sterile quality.
A COA reports selected findings for the tested sample. It does not establish an approved human use, sterile suitability or pharmaceutical equivalence.
- Product and chemical identity, including oxidized or reduced form
- Batch or lot number and sample identification
- Listed amount and package format
- Chromatographic purity and method details
- Expected and observed molecular mass where reported
- Water content or degradation-related peaks where tested
- Laboratory, testing date and report limitations
- Separate microbial, endotoxin or sterility results where performed
How should laboratories approach storage and handling?
Follow verified product-specific storage documentation and institutional procedures for the exact NAD+ format and batch.
- Keep formats and batches clearly identified and matched to the correct COA.
- Record storage conditions, duration and environmental exposure.
- Protect material from light, moisture or temperature exposure where documentation specifies.
- Review stability information for the exact product form.
- Follow institutional handling and disposal procedures.
Frequently Asked Questions
What is NAD+?
NAD+ is a nucleotide-based cellular coenzyme involved in electron transfer and NAD-dependent enzyme signaling.
What does NAD stand for?
Nicotinamide adenine dinucleotide.
Is NAD+ a peptide?
No. NAD+ is a nucleotide-based cellular coenzyme. Peptides are chains of amino acids, while NAD+ has a different chemical structure and biological classification.
Is NAD+ a vitamin?
No. NAD+ is not itself a vitamin. Cells can produce NAD+ using vitamin B3-related compounds such as niacin and nicotinamide.
What is the difference between NAD+ and NADH?
NAD+ is the oxidized electron-accepting form; NADH is the reduced electron-carrying form. They cycle between forms in redox reactions.
Why do cells need NAD+?
Cells use NAD+ in metabolic electron transfer and as a substrate for enzyme systems including sirtuins, PARPs and CD38.
What is NAD+ studied for?
Researchers study NAD+ in cellular energy metabolism, redox balance, mitochondrial biology, DNA-response pathways and NAD-dependent enzyme signaling.
How is NAD+ related to mitochondria?
NADH transfers reducing equivalents into mitochondrial pathways, while regeneration of NAD+ helps sustain continuing metabolic reactions.
What are sirtuins?
Sirtuins are NAD-dependent enzymes studied in metabolic regulation, gene-expression control, stress responses and mitochondrial biology.
What is the difference between NAD+ and NMN?
NAD+ is the complete coenzyme. NMN is a precursor that cells may use in NAD+ biosynthesis.
What is the difference between NAD+ and NR?
NR is nicotinamide riboside, a structurally distinct precursor studied as an input to NAD+ biosynthesis.
Are NAD+ precursors the same as NAD+?
No. Compounds such as NMN and NR may be used by cells in NAD+ biosynthesis, but they have different structures, absorption pathways and research evidence.
Do NAD+ levels change with age?
Many studies report age-associated changes in tissue NAD+ metabolism, but patterns vary by tissue, species, measurement and study context.
Are there human studies involving NAD+?
Yes, but much human literature evaluates NADH, NAD+ precursors or related biomarkers rather than direct outcomes from NAD+ itself.
Does NAD+ increase energy?
NAD+ is required for many cellular reactions involved in energy metabolism. That biochemical role does not establish that a commercial NAD+ product reliably increases a person’s perceived energy.
Is NAD+ proven to reverse aging?
No. NAD+ metabolism is widely studied in aging research, but evidence does not establish that a commercial NAD+ product reverses human aging.
Is NAD+ FDA approved?
NAD+ itself is a naturally occurring cellular molecule. Ryse NAD+ products are not represented as FDA-approved drugs.
What did FDA say about compounded NAD+?
FDA warned that food-grade NAD+ is not suitable for products intended to be sterile without appropriate ingredient quality and processing controls because microbial and endotoxin contamination may present risks. That warning is not an approval of NAD+ therapy.
Are Ryse NAD+ strips and vials equivalent?
No. They are separate formats with different package specifications and potentially different analytical and stability considerations. Review documentation for the exact product and batch.
What should researchers look for on an NAD+ COA?
Match identity, format, listed amount, batch, laboratory and date; then review purity, molecular-mass evidence, methods and any separately reported microbial, endotoxin or sterility testing.
Does a COA establish sterility?
No. Identity and purity testing do not establish sterility or endotoxin status unless those evaluations are performed and reported separately.
What does Research Use Only mean?
The material is offered for legitimate laboratory research where legally permitted, not for human or veterinary consumption.
Is this page medical advice?
No. It provides scientific and laboratory-research literacy without dosing, preparation, administration or personal-use guidance.
Selected NAD+ Studies
References are provided for scientific-literacy purposes. Human studies involving NAD+ precursors should not be interpreted as direct evidence for the Ryse NAD+ products.
NAD+ metabolism and its roles in cellular processes during ageing
An authoritative review of NAD+ redox chemistry, biosynthesis, consumption and cellular functions. Mechanistic findings do not establish a commercial-product outcome.
Regulation of NAD+ metabolism in aging and disease
A review of NAD+ metabolism, precursor pathways and age-associated biology across preclinical evidence.
What is really known about the effects of nicotinamide riboside supplementation in humans
A critical review of human NR trials that emphasizes the limited clinical relevance of many reported effects. NR evidence is precursor evidence, not direct evidence for NAD+ products.
FDA reminds compounders to use ingredients suitable for sterile compounding
FDA’s notice explains why food-grade NAD+ is not suitable for sterile drug compounding without appropriate controls and identifies microbial and endotoxin concerns.
Research Use Only
Information on this page is provided solely for general scientific education and laboratory-research literacy. It is not medical or veterinary advice and does not provide dosing, reconstitution, administration or personal-use guidance.
NAD+ is a naturally occurring cellular coenzyme rather than a peptide. Published research involving NAD+ biology, NAD+ precursors, clinical formulations or compounded preparations does not establish outcomes for a Ryse laboratory product or verify pharmaceutical equivalence.
Ryse Peptides products are intended only for legitimate laboratory research where legally permitted. They are not intended for human or veterinary consumption or to diagnose, treat, cure, mitigate or prevent disease.